3 views left Get unlimited views with a free account

Subscribe to GlobalData Explorer

Explore the latest trends and actionable insights on Therapy Areas to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Craniopharyngioma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 8 ongoing clinical trials involving Craniopharyngioma
Of the 8 trials,5 trials are in Phase II
Furthermore, 2 trials are in Phase 0

Number of ongoing Clinical Trials (for drugs) involving Craniopharyngioma by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Craniopharyngioma, an Oncology indication. The largest number of ongoing clinical trials of Craniopharyngioma is conducted in North America. Asia-Pacific is the other prominent region involved in Craniopharyngioma-related drug trials.

Craniopharyngioma related clinical trial sponsors
West China Hospital of Sichuan University, Nascent Biotech Inc, Rhythm Pharmaceuticals Inc, Suzhou Neupharma Co Ltd, and Children's Hospital Colorado are a few notable clinical trial sponsors involved in Craniopharyngioma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.

Explore the latest trends and actionable insights on Therapy Areas to inform business strategy and pinpoint opportunities and risks. Explore the latest trends and actionable insights on Therapy Areas to inform business strategy and pinpoint opportunities and risks. Visit Report Store